Table 3

DAS28 response data by genotype and association p values for 17 successfully genotyped SNPs in 1012 individuals

First cohort (n=1012)
Additive modelDominant model*
SNPGeneChrbpGenotypeCountMean baseline DAS28SD baseline DAS28Mean change in DAS28SD change in DAS28HWE exact p valueGenotypic global p valueGlobal p valueCoefMin 95Max 95Global p valueCoefMin 95Max 95
rs10865035AFF32100202166AA2406.721.02−2.281.570.0890.0510.018−0.16−0.29−0.030.024−0.25−0.46−0.03
AG5326.690.96−2.511.51
GG2376.680.99−2.581.63
rs1160542AFF32100198587AA2476.700.97−2.591.610.0500.0660.0220.150.020.290.1010.17−0.030.38
AG5306.690.96−2.491.51
GG2216.681.00−2.251.56
rs7574865STAT42191672878GG5646.730.99−2.571.550.4000.0510.0940.13−0.020.280.0280.200.020.39
GT3896.650.95−2.331.58
TT576.641.10−2.491.40
rs10181656STAT42191678124CC5636.730.99−2.571.540.5590.0670.1220.12−0.030.270.0380.190.010.37
CG3896.650.95−2.331.60
GG606.631.07−2.501.37
rs231775CTLA42204440959AA3656.681.00−2.501.530.7940.7750.5000.04−0.090.170.4840.07−0.120.25
AG4826.690.98−2.441.52
GG1656.730.94−2.521.72
rs3087243CTLA42204447164GG3406.670.97−2.531.640.9480.7120.5700.04−0.090.170.4270.08−0.110.27
GA4926.740.96−2.461.49
AA1766.611.05−2.411.57
rs6822844IL2–IL214123728871GG7256.690.95−2.451.580.1510.3760.317−0.09−0.260.080.208−0.13−0.330.07
GT2546.681.05−2.521.50
TT317.000.84−2.701.33
rs13192841TNFAIP36138008907GG5776.660.98−2.501.590.6720.4060.4690.05−0.090.200.2710.10−0.080.28
GA3716.720.99−2.411.51
AA646.770.92−2.601.48
rs6920220TNFAIP36138048197GG5256.690.96−2.491.490.4300.5360.3140.07−0.070.220.2650.10−0.080.28
GA4136.691.00−2.441.61
AA716.681.02−2.431.68
rs5029937TNFAIP36138236844GG9006.670.98−2.441.540.7630.4630.216−0.18−0.470.110.227−0.18−0.480.11
GT1056.910.92−2.731.64
TT27.460.35−3.431.01
rs2812378CCL21934700260TT3796.671.02−2.421.530.3860.8760.637−0.03−0.170.100.609−0.05−0.240.14
TC4906.700.95−2.511.56
CC1406.740.96−2.481.62
rs10760130TRAF19122741811AA3136.710.99−2.391.580.7980.4570.9810.00−0.130.130.520−0.06−0.260.13
AG4926.680.94−2.541.53
GG2006.711.07−2.411.57
rs2900180TRAF19122746203CC4256.730.98−2.471.610.0770.7300.5920.04−0.090.170.8410.02−0.160.20
CT4416.650.95−2.501.49
TT1466.701.05−2.411.57
rs4750316PRKCQ106433266GG6956.710.95−2.541.560.5100.3460.3870.07−0.090.240.2370.12−0.080.31
GC2836.671.01−2.331.50
CC336.431.23−2.191.80
rs1678542KIF5A1256254982CC4196.720.98−2.501.550.4480.7240.6000.04−0.100.170.4560.07−0.110.25
CG4736.650.96−2.441.55
GG1196.741.05−2.491.56
rs763361CD2261865682622TT2726.651.00−2.641.500.9000.0500.0160.160.030.290.0260.230.030.43
TC5086.690.96−2.451.57
CC2326.750.98−2.321.57
rs4810485CD402044181354GG6076.680.95−2.501.540.0480.3980.2210.10−0.060.270.3250.09−0.090.28
GT3586.681.01−2.401.56
TT356.900.97−2.461.65
  • Significant p values (<0.05) are shown in bold type, italic indicates p<0.10.

  • * Results for the recessive model are not shown; only rs1160542 (AFF3) demonstrated association with treatment response under a recessive model (coef 0.23 (0.01, 0.45), p=0.037).

  • bp, base pairs; Chr, chromosome; Coef, coefficient for minor allele; DAS, disease activity score; HWE, Hardy–Weinberg equilibrium; SNP, single nucleotide polymorphism.